DIANA RICHARDS: Open Payments
NPI 1457412819 · ANN ARBOR, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,611 in 17 payments from 14 companies in 2025. Trend: 2023 $403 · 2024 $829 · 2025 $1,611
Food & beverage: $1,611
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 2 | $204 |
| Alnylam Pharmaceuticals Inc. | 1 | $141 |
| Boston Scientific Corporation | 1 | $134 |
| Axsome Therapeutics, Inc. | 2 | $128 |
| Amgen Inc. | 1 | $125 |
| Astellas Pharma US Inc | 1 | $122 |
| JAZZ PHARMACEUTICALS INC. | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Gilead Sciences, Inc. | 1 | $112 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $101 |
Products named: ULTOMIRIS, AMVUTTRA, WATCHMAN FLX, Auvelity, EVENITY, Veozah, EPIDIOLEX, UZEDY.
Industry payments across MI — which companies pay providers there.
